Skip to content
★ Sign in to follow
RM

Rosemary Mazanet

Directeur Scientifique
Cannabist Co Holdings Inc.Oncternal Therapeutics, Inc.Actinium Pharmaceuticals, Inc.
Total declarations
44
Companies
3
▲ Purchases (1 ops.)
€307
▼ Sales (0 ops.)
—

Latest filing published 07 Apr 2025 for Cannabist Co Holdings Inc..

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Rosemary Mazanet: trading record in brief

Rosemary Mazanet (senior executive) discloses dealings in 3 companies, chiefly Cannabist Co Holdings Inc., Oncternal Therapeutics, Inc. and Actinium Pharmaceuticals, Inc. We count 44 filings; the first trade dates from 1 January 2006 and the latest from 5 April 2025.

On the market, this insider has only ever bought: 1 purchase, €307 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 27 share grants and 16 option exercises.

The record was last updated on 7 April 2025 with an option exercise in Cannabist Co Holdings Inc. The latest purchase dates back some time: it was published 4,919 days ago, on 22 May 2013. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Rosemary Mazanet

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations30 total

25 of 30 declarations